H. Lundbeck A/S (HLUBF)
H. Lundbeck Market Cap : 8.284B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2026 | 8.284B |
| November 12, 2026 | 8.284B |
| November 11, 2026 | 7.878B |
| November 10, 2026 | 7.878B |
| November 09, 2026 | 7.878B |
| November 06, 2026 | 6.796B |
| November 05, 2026 | 6.796B |
| November 04, 2026 | 6.796B |
| November 03, 2026 | 6.796B |
| November 02, 2026 | 6.796B |
| October 30, 2026 | 6.796B |
| October 29, 2026 | 6.796B |
| October 28, 2026 | 6.796B |
| October 27, 2026 | 6.796B |
| October 26, 2026 | 6.796B |
| October 23, 2026 | 6.796B |
| October 22, 2026 | 6.796B |
| October 21, 2026 | 6.796B |
| October 20, 2026 | 6.796B |
| October 19, 2026 | 6.796B |
| October 16, 2026 | 6.796B |
| October 15, 2026 | 6.796B |
| October 14, 2026 | 6.796B |
| October 13, 2026 | 6.796B |
| October 12, 2026 | 6.796B |
| Date | Value |
|---|---|
| October 09, 2026 | 6.796B |
| October 08, 2026 | 6.796B |
| October 07, 2026 | 6.350B |
| October 06, 2026 | 6.350B |
| October 05, 2026 | 6.350B |
| October 02, 2026 | 6.350B |
| October 01, 2026 | 6.350B |
| September 30, 2026 | 6.350B |
| September 29, 2026 | 6.350B |
| September 28, 2026 | 6.350B |
| September 25, 2026 | 6.350B |
| September 24, 2026 | 6.350B |
| September 23, 2026 | 6.350B |
| September 22, 2026 | 6.350B |
| September 21, 2026 | 6.350B |
| September 18, 2026 | 6.350B |
| September 17, 2026 | 6.350B |
| September 16, 2026 | 6.350B |
| September 15, 2026 | 6.350B |
| September 14, 2026 | 6.733B |
| September 11, 2026 | 6.508B |
| September 10, 2026 | 5.500B |
| September 09, 2026 | 5.500B |
| September 08, 2026 | 5.500B |
| September 04, 2026 | 5.500B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Novo Nordisk A/S | 139.21B |
| ALK-Abello A/S | 8.099B |
| AstraZeneca PLC | 570.40B |
| ANI Pharmaceuticals, Inc. | 1.625B |
| Corcept Therapeutics, Inc. | 7.570B |
Market Cap Related Metrics
| PE Ratio | 13.17 |
| PS Ratio | 2.037 |
| PEG Ratio | 0.9861 |
| Price to Book Value | 1.930 |
| Price to Free Cash Flow | 11.52 |
| Price | 8.35 |
| Earnings Yield | 7.59% |
| PEGY Ratio | 0.847 |
| Operating PE Ratio | 7.985 |
| Normalized PE Ratio | 12.31 |